Method and composition for increasing the accumulation of squalene and specific sterols in yeast
AssigneeAmoco Corporation
InventorsCourt A. Saunders, Fred R. Wolf, Indrani Mukharji
Life of this patent
Estimating the term…
Loading patent…
AssigneeAmoco Corporation
InventorsCourt A. Saunders, Fred R. Wolf, Indrani Mukharji
Estimating the term…
A method of increasing the accumulation of squalene and specific sterols in yeast comprising increasing the expression level of a structural gene encoding a polypeptide having HMG-CoA reductase activity in a mutant yeast having single or double defects in the expression of sterol biosynthetic enzymes is provided. The expression level of a structural gene is preferably increased by transforming yeast with a recombinant DNA molecule comprising a vector operatively linked to an exogenous DNA segment that encodes a polypeptide having HMG-CoA reductase activity and a promoter that is suitable for driving the expression of the encoded polypeptide in the transformed yeast. The polypeptide having HMG-CoA reductase activity is preferably a truncated, active HMG-CoA reductase enzyme. Recombinant DNA molecules useful for transforming yeast and mutant yeast transformed with such recombinant DNA molecules are also disclosed.
A method of increasing squalene, zymosterol, cholesta-7,24-dienol and cholesta-5,7,24-trienol accumulation in mutant yeast comprising increasing the expression level of a structural gene encoding a polypeptide having HMG-CoA reductase activity in a mutant yeast having defects in the expression of zymosterol-24-methyltransferase and ergosta-5,7,24(28)-trienol-22-dehydrogenase;
A mutant S. cerevisiae having defects in the expression of zymosterol-24-methyltransferase and ergosta-5,7,24(28)-trienol-22-dehydrogenase enzymes, which mutant species is designated ATC0402mu.
A mutant of S. cerevisiae having single or double defects in the expression of enzymes that catalyze the conversion of squalene to ergosterol transformed with a recombinant DNA molecule comprising a vector operatively linked to an exogenous DNA segment that encodes an HMG-CoA reductase enzyme and a promoter suitable for driving the expression of said reductase in said yeast.
A recombinant DNA molecule designated plasmid pARC304S.
A recombinant DNA molecule designated plasmid pARC300S.
A recombinant DNA molecule designated plasmid pARC300T.
A recombinant DNA molecule designated plasmid pARC300D.
A recombinant DNA molecule designated plasmid pARC306E.
A recombinant DNA molecule designated plasmid pSOC106ARC.
A recombinant DNA molecule designated plasmid pSOC725ARC.
A method of increasing squalene, ergosta-8,22-dienol, ergosta-7,22-dienol, ergosta-8-enol, and ergosta-7-enol accumulation in mutant yeast of the species S. cerevisiae comprising transforming a mutant S. cerevisiae having a defect in the expression of episterol-5-dehydrogenase with a recombinant DNA molecule comprising a vector operatively linked to an exogenous DNA segment that encodes a polypeptide that is an active, truncated HMG-CoA reductase enzyme, and a promoter suitable for driving the expression of said reductase in said mutant yeast to form transformed mutant yeast;
A method of increasing squalene, zymosterol and cholesta-7,24-dienol accumulation in mutant yeast of the species S. cerevisiae comprising transforming a mutant S. cerevisiae having a defect in the expression of zymosterol-24-methyltransferase and episterol-5-dehydrogenase with a recombinant DNA molecule comprising a vector operatively linked to an exogenous DNA segment that encodes a polypeptide that is an active, truncated HMG-CoA reductase enzyme, and a promoter suitable for driving the expression of said reductase in said yeast to form transformed mutant yeast;
A method of increasing squalene, zymosterol, ergosta-5,7,24(28)-trienol and ergosta-5,7-dienol accumulation in mutant yeast of the species S. cerevisiae comprising transforming a mutant S. cerevisiae having a defect in the expression of ergosta-5,7,24(28)-trienol-22-dehydrogenase with a recombinant DNA molecule comprising a vector operatively linked to an exogenous DNA segment that encodes a polypeptide that is an active, truncated HMG-CoA reductase enzyme, and a promoter suitable for driving the expression of said reductase enzyme, and a promoter suitable for driving the expression of said reductase in said mutant yeast to form transformed mutant yeast;
Dependencies are inferred from the claim text.